The U.S. Food and Drug Administration said the number of serious injuries linked to the devices had risen to 860.
An exhibit from Abbott is seen at the Las Vegas Convention Center during the Consumer Electronics Show on Jan. 10, 2024. Brendan Smialowski/AFP via Getty Images
|Updated:
The U.S. Food and Drug Administration (FDA) has classified Abbott Diabetes Care’s November 2025 recall of certain glucose monitoring sensors as the “most serious type” and said that the company had reported 860 cases of serious injuries linked to the devices.
Abbott Diabetes Care is a division of Abbott Laboratories.
Mary Prenon
Freelance Reporter
Mary T. Prenon covers real estate and business. She has been a writer and reporter for over 25 years with various print and broadcast media in New York.
